What is the best management approach for Erythema nodosum (Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, corticosteroids such as prednisone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Erythema Nodosum

For erythema nodosum, NSAIDs (such as ibuprofen or naproxen) are the first-line treatment for symptomatic relief, with systemic corticosteroids reserved only for severe cases after excluding infectious causes, particularly tuberculosis. 1, 2

Initial Treatment Approach

First-Line Therapy: NSAIDs

  • NSAIDs are the cornerstone of symptomatic treatment for pain and inflammation in erythema nodosum 1
  • Effective options include ibuprofen, naproxen, indomethacin, or aspirin 2, 3
  • These agents typically provide sufficient analgesia and enhance resolution of nodules 2
  • Bed rest and leg elevation are important adjunctive measures that accelerate improvement 2, 4

Address Underlying Causes

  • Identify and treat any precipitating condition: streptococcal pharyngitis (most common in children), sarcoidosis (common in adults), inflammatory bowel disease, or fungal infections 1, 4
  • For streptococcal infection, appropriate antibiotic therapy is essential 4
  • For Behçet's disease-associated erythema nodosum, colchicine is the preferred treatment 5, 1

When to Use Corticosteroids

Indications for Systemic Corticosteroids

  • Reserve corticosteroids for severe cases with significant inflammation or IBD-associated erythema nodosum 1
  • Corticosteroids are highly effective but rarely indicated due to the self-limited nature of erythema nodosum 2, 3

Critical Caveat: Rule Out Infection First

  • Before administering corticosteroids, you must exclude underlying infections, particularly tuberculosis and fungal infections 2, 6
  • Risk-stratify patients for tuberculosis with purified protein derivative testing and chest radiography as needed 4
  • For coccidioidomycosis-associated erythema nodosum, antifungal therapy is not recommended; NSAIDs alone are sufficient 1

Refractory or Recurrent Cases

Second-Line Immunomodulatory Therapy

  • For frequent relapses or IBD-associated erythema nodosum, consider azathioprine or TNF-alpha inhibitors (infliximab or adalimumab) 1
  • Colchicine is particularly effective when erythema nodosum is associated with Behçet's syndrome 5, 1
  • For sarcoidosis-associated cases, hydroxychloroquine may be added to standard therapy 1

Additional Options

  • Potassium iodide may be helpful to enhance analgesia and resolution 2
  • Topical or oral calcineurin inhibitors are alternatives in resistant cases, though dermatological consultation is recommended 5

Common Pitfalls to Avoid

  • Do not use corticosteroids without first excluding infectious etiologies, as steroids risk disseminating underlying infections like tuberculosis or fungal disease 2, 6, 7
  • Do not overlook the need to monitor for disease activity in associated conditions like inflammatory bowel disease or sarcoidosis 1
  • Recognize that over 50% of patients may have recurrent episodes, which warrants reassessment for persistent underlying disease 1, 7
  • Remember that erythema nodosum is self-limited in most cases, resolving spontaneously within weeks without scarring or ulceration 2, 4, 3

References

Guideline

Erythema Nodosum: Clinical Presentation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Erythema nodosum.

Seminars in cutaneous medicine and surgery, 2007

Research

Erythema nodosum.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2013

Research

Erythema nodosum: a sign of systemic disease.

American family physician, 2007

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Systemic manifestations of erythema nodosum.

California medicine, 1956

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.